Corcept Therapeutics Inc (CORT)
22.21
-0.27
(-1.20%)
USD |
NASDAQ |
Apr 25, 16:00
22.50
+0.29
(+1.31%)
Pre-Market: 20:00
Corcept Therapeutics Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.0691 |
| March 31, 2017 | 0.2039 |
| December 31, 2016 | 0.3544 |
| September 30, 2016 | 0.5993 |
| June 30, 2016 | 0.7232 |
| March 31, 2016 | 0.8093 |
| December 31, 2015 | 0.809 |
| September 30, 2015 | 1.002 |
| June 30, 2015 | 1.044 |
| March 31, 2015 | 1.008 |
| December 31, 2014 | -2.782 |
| September 30, 2014 | -6.576 |
| June 30, 2014 | 2.142 |
| March 31, 2014 | 0.7359 |
| December 31, 2013 | 0.2733 |
| September 30, 2013 | 0.1462 |
| June 30, 2013 | 0.0904 |
| March 31, 2013 | 0.0765 |
| December 31, 2012 | 0.0429 |
| September 30, 2012 | 0.4267 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
--
Maximum
Jun 2019
--
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
| Ultragenyx Pharmaceutical Inc | 0.00 |
| Alnylam Pharmaceuticals Inc | -4.626 |
| Catalyst Pharmaceuticals Inc | 0.00 |
| United Therapeutics Corp | 0.117 |
| XOMA Corp | 1.398 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 621.52M |
| Total Liabilities (Quarterly) | 114.81M |
| Shareholders Equity (Quarterly) | 506.70M |
| Current Ratio | 4.389 |